References
- Brill, N. Q., Koegler, R. R., Epstein, L. J., and Forgy, E. W., (1964). Controlled study of psychiatric outpatient treatment. Arch. Gen. Psychiat., 10, 581, as quoted in Hollister, L. E., (1970). Methodological considerations in evaluating antianxiety drugs. J. clin. Pharmacol., 10, 12–18.1. Brill, N. Q., Koegler, R. R., Epstein, L. J., and Forgy, E. W., (1964). Controlled study of psychiatric outpatient treatment. Arch. Gen. Psychiat., 10, 581, as quoted in Hollister, L. E., (1970). Methodological considerations in evaluating antianxiety drugs. J. clin. Pharmacol., 10, 12–18.
- Proceedings(1972). Summary of Selected Proceedings of the V World Congress of Psychiatry, Mexico City, November 28-December 4, 1971. Excerpta Medica Foundation, Amsterdam.2. Proceedings, (1972). Summary of Selected Proceedings of the V World Congress of Psychiatry, Mexico City, November 28-December 4,1971. Excerpta Medica Foundation, Amsterdam.
- Hamilton, M., (1959). The assessment of anxiety states by rating. Brit. J. med. Psychol, 32, 50–55.3. Hamilton, M., (1959). The assessment of anxiety states by rating. Brit. J. med. Psychol, 32, 50–55.
- De Buck, R., Boon, H., and Pelc, I., (1972). A double-blind cross-over comparative study of the anxiolytic effect of lorazepam (Wy-4036) and diazepam (Valium). Summary of Selected Proceedings of the V World Congress of PsychiatryMexico CityNovember-December28-41971. Excerpta Medica Foundation, Amsterdam, p.7–12.4. De Buck, R., Boon, H., and Pelc, I., (1972). A double-blind cross-over comparative study of the anxiolytic effect of lorazepam (Wy-4036) and diazepam (Valium). Summary of selected Proceedings of the V World Congress of Psychiatry, Mexico City, November 28-December 4,197 1. Excerpta Medica Foundation, Amsterdam, p.7–12.
- Haider, I., (1971). A comparative trial of lorazepam and diazepam. Brit. J. Psychiat., 119, 599–600.5. Haider, I., (1971). A comparative trial of lorazepam and diazepam. Brit. J. Psychiat., 119, 599–600.
- Haider, I., (1971). Evaluation of a new tranquillizer - Wy 4036 - in the treatment of anxiety. Brit. J. Psychiat., 119, 597–598.6. Haider, I., (1971). Evaluation of a new tranquillizer - Wy 4036 - in the treatment of anxiety. Brit. J. Psychiat., 119, 597–598.